MetaCap

Kyverna Therapeutics (KYTX) News

NASDAQ: KYTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

4.26-0.11 (-2.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

KYTX news summary

We found 8 recent headlines mentioning Kyverna Therapeutics (KYTX): 0 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, KYTX is down 2.52% at $4.26. The most recent story, "Kyverna Therapeutics, Inc. Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Kyverna Therapeutics headlines

Stocks mentioned alongside KYTX

Compare KYTX